MiNK Therapeutics INKT Stock
MiNK Therapeutics Price Chart
MiNK Therapeutics INKT Financial and Trading Overview
| MiNK Therapeutics stock price | 8.75 USD |
| Previous Close | 2.27 USD |
| Open | 2.3 USD |
| Bid | 2.34 USD x 3000 |
| Ask | 2.49 USD x 900 |
| Day's Range | 2.22 - 2.99 USD |
| 52 Week Range | 0.85 - 4.32 USD |
| Volume | 600.67K USD |
| Avg. Volume | 149.71K USD |
| Market Cap | 82.61M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.86 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
INKT Valuation Measures
| Enterprise Value | 63.25M USD |
| Trailing P/E | N/A |
| Forward P/E | -3 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.159 |
Trading Information
MiNK Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 49.06% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.32 USD |
| 52 Week Low | 0.85 USD |
| 50-Day Moving Average | 1.9 USD |
| 200-Day Moving Average | 2.18 USD |
INKT Share Statistics
| Avg. Volume (3 month) | 149.71K USD |
| Avg. Daily Volume (10-Days) | 134.8K USD |
| Shares Outstanding | 34.42M |
| Float | 9.76M |
| Short Ratio | 0.47 |
| % Held by Insiders | 86.11% |
| % Held by Institutions | 1.91% |
| Shares Short | 154.08K |
| Short % of Float | 3.04% |
| Short % of Shares Outstanding | 0.44% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.76% |
| Return on Equity (ttm) | -403.66% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -29288728 USD |
| Net Income Avi to Common (ttm) | -25900152 USD |
| Diluted EPS (ttm) | -0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.89M USD |
| Total Cash Per Share (mrq) | 0.43 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.38 |
| Book Value Per Share (mrq) | -0.13 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19036768 USD |
| Levered Free Cash Flow (ttm) | -22779522 USD |
Profile of MiNK Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | 149 Fifth Avenue |
| ZIP | 10010 |
| Phone | 212 994 8250 |
| Website | https://minktherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 37 |
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.
Q&A For MiNK Therapeutics Stock
What is a current INKT stock price?
MiNK Therapeutics INKT stock price today per share is 8.75 USD.
How to purchase MiNK Therapeutics stock?
You can buy INKT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MiNK Therapeutics?
The stock symbol or ticker of MiNK Therapeutics is INKT.
Which industry does the MiNK Therapeutics company belong to?
The MiNK Therapeutics industry is Biotechnology.
How many shares does MiNK Therapeutics have in circulation?
The max supply of MiNK Therapeutics shares is 3.97M.
What is MiNK Therapeutics Price to Earnings Ratio (PE Ratio)?
MiNK Therapeutics PE Ratio is now.
What was MiNK Therapeutics earnings per share over the trailing 12 months (TTM)?
MiNK Therapeutics EPS is -2.86 USD over the trailing 12 months.
Which sector does the MiNK Therapeutics company belong to?
The MiNK Therapeutics sector is Healthcare.
MiNK Therapeutics INKT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}